I. Introduction
Electrical impedance myography (EIM) is a technology that is finding increasing application to assess neuromuscular disorders (NMD) [1]–[3]. EIM relies on the four-terminal electrical impedance technique [4], namely the application of an alternating electrical current across a region of muscle and the measurement of the resulting electrical voltage response. The underlying scientific premise of EIM is that structural and morphological alterations in pathological tissue (e.g., myofiber atrophy, inflammation, edema, and fat infiltration) change the intrinsic electrical properties of muscle, and these changes can be detected in the measured impedance [5]. This important feature allows EIM to serve both as a primary diagnostic test as well as a method for tracking disease progression or response to therapy. In point of fact, EIM has already been employed to follow disease progression in a number of clinical studies including amyotrophic lateral sclerosis and Duchenne muscular dystrophy [6]–[8].